- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05138354
Standard Care With LLLT & Myofascial Release Versus Standard Care Alone in Pregnant Women With Temporomandibular Disorder
November 18, 2021 updated by: Mohamed Magdy Ali Hassan ElMeligie, October 6 University
Standard Care Combined With Low-Level Laser Therapy and Myofascial Release Versus Standard Care Alone in Pregnant Women With Temporomandibular Disorder: A Randomized Controlled Trial
This study will investigate a novel approach to treat pregnant women with tempromandibular disorder using a combined method of low level laser therapy, myofascial release and standard care versus standard care alone.
It's hopeful that the results of this study can fill the gap of knowledge surrounding the conservative treatment options for TMD in order to help patients restore their oral function properly and promote new ways of addressing TMD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Giza
-
Al Ḩayy Ath Thāmin, Giza, Egypt, 12511
- October 6 university hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women diagnosed with myofascial TMD according to the Research Diagnostic Criteria for Temporomandibular Disorders
Exclusion Criteria:
- facial neuro-musculoskeletal pathologies (i.e., facial trauma and/or fractures, and bell's palsy)
- acute infections or systemic disorders
- osteoporosis
- cervical spine or upper limb dysfunction
- steroid infiltration4
- any recent dental treatment taken or surgery over TMJ
- hypermobile joint
- neurological impairments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
Patients received a 4-week treatment program (12 treatment sessions, three times a week).
Patients received the conservative treatment protocol comprised of ultrasound, hot pack application, and exercises.
|
Active exercises for mandibular muscles will be used to correct the mouth opening
|
Experimental: Intervention group
Patients received a 4-week treatment program (12 treatment sessions, three times a week).
Patients received LLLT and myofascial release combined with the control intervention.
the conservative treatment protocol comprised of ultrasound, hot pack application, and exercises
|
Active exercises for mandibular muscles will be used to correct the mouth opening
MLS® device (ASA Srl, Vicenza, Italy) IR laser with two synchronized sources (laser diodes) and a wavelength of 808 nm to deliver the intervention.
The laser probe will be held vertically in contact with the skin to deliver the irradiation at three mandibular condyle points (front, behind and over) and one point at the external acoustic meatus.
The irradiation will be applied with a laser bean of 3.14 cm² diameter for 14 seconds at each place using a pulse rate of 1500 Hz, pulse duration of 100ns, and energy density: 16 J/cm².
Patients will be positioned in supine in a treatment table.
The therapist seated beside the patient at the side of affected temporomandibular joint to apply gross release technique for masseter, pterygoid and temporalis muscles.
At each point, the therapist applied the technique for 90 seconds and repeated 5 times during the session (5 seconds of rest between each repetition).(15)
The therapist worn gloves to deliver the intraoral myofascial release.
In case the patient reported any latex allergies, the gloves were replaced by a latex free model.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in visual analogue scale
Time Frame: Baseline and after 4 weeks
|
Visual analog scale (VAS), a grading scale range from 0 to 100 mm.
0 mm represented no pain or discomfort at all and 100 mm represented the greatest amount of pain or discomfort imaginable.
Participant drew a line that intersects the grading scale to show the amount of pain or discomfort that he or she experienced at that moment.
The assessor then used a ruler to measure the length from 0 mm to the intersecting line and recorded the value.
|
Baseline and after 4 weeks
|
Changes in pain pressure threshold (PPT)
Time Frame: Baseline and after 4 weeks
|
Comparing pain pressure threshold differences on both sides over TMJ, masseter and anterior temporalis.
|
Baseline and after 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Limitations of daily function in temporomandibular disorder questionnaire
Time Frame: Baseline and after 4 weeks
|
The limitations in daily functions in the temporomandibular disorder questionnaire (LDF-TMDQ) assess participants' functionality by asking them to report how much the jaw problem prevents or limits their performance in a list of 10 daily activities
|
Baseline and after 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Radwa M Yehia, Ph.D, Faculty of Physical Therapy, October 6 University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 18, 2021
Primary Completion (Actual)
October 26, 2021
Study Completion (Actual)
October 26, 2021
Study Registration Dates
First Submitted
November 18, 2021
First Submitted That Met QC Criteria
November 18, 2021
First Posted (Actual)
December 1, 2021
Study Record Updates
Last Update Posted (Actual)
December 1, 2021
Last Update Submitted That Met QC Criteria
November 18, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PTMD2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
all of the individual participant data collected during the trial and after deidentification
IPD Sharing Time Frame
6 Months after study publication
IPD Sharing Access Criteria
Email: mohamed.magdy.pt@o6u.edu.eg
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Temporomandibular Disorder
-
CES UniversityCompletedTemporomandibular Disorder | Children, Only | Pain Disorder | Joint Disorder, Temporomandibular
-
University of AlcalaCompletedTemporomandibular DisorderSpain
-
University of Nove de JulhoUnknownTemporomandibular DisorderBrazil
-
Fundació Universitària del BagesUniversitat Internacional de Catalunya; Hospital Universitari Sagrat Cor; Clinicas...Not yet recruitingFatigue | Temporomandibular Disorder | Chewing Problem | Mastication Disorder | Orofacial PainSpain
-
University of AlcalaRecruitingTemporomandibular DisorderSpain
-
Chulalongkorn UniversityCompletedTemporomandibular DisorderThailand
-
Indiana UniversityNovartis PharmaceuticalsCompletedTemporomandibular DisorderUnited States
-
Pomeranian Medical University SzczecinCompletedTemporomandibular Disorder
-
OrigenKinesis fisioterapiaUniversidad Rey Juan CarlosNot yet recruiting
-
University of Nove de JulhoNot yet recruiting
Clinical Trials on Standard care
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
University of OklahomaCompletedTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency ManagementUnited States
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Institut de Cancérologie de LorraineTerminatedBreast CancerFrance
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
brett rasmussenCompleted